Table 4: Recommended dose reduction levels for lenalidomidea and dexamethasoneb

From: Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement

Dose levelLenalidomide dose (mg)Dexamethasone dose (mg)
Starting dose2540
11520
21010
350c
  1. a For grade 3/4 neutropenia, thrombocytopenia or other adverse events.
  2. b For dexamethasone-related adverse events (for example, myopathy, chronic non-neutropenic infection, psychological changes and hyperglycemia).
  3. c Discontinuation of dexamethasone.